SurGraft® ACA is a triple-layer allograft comprised of amnion, chorion, and amnion layers. It is meticulously designed for wound coverage, using a proprietary manufacturing process, and serves as a protective barrier to facilitate optimal wound care.
SurGraft® ACA is processed in compliance with the United States Food and Drug Administration current Good Tissue Practices (cGTP) Regulations and the American Association of Tissue Banks Standards. We pride ourselves on quality and testing that meet or exceed industry standards.
SurGraft® ACA functions as a protective covering for managing acute and chronic, non-healing wounds, including diabetic, pressure, and venous ulcers.
SurGraft® ACA is regulated under Section 361 of the PHS Act and FDA 21 CFR Part 1271 and is intended for homologous use.
HCPCS Level II Code Q4394, "SurGraft ACA, per square centimeter"
